ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.35
0.125 (10.20%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.125 10.20% 1.35 1.30 1.40 1.35 1.20 1.23 8,345,835 16:20:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.26 10.47M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.23p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £10.47 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.26.

Shield Therapeutics Share Discussion Threads

Showing 6676 to 6698 of 23175 messages
Chat Pages: Latest  279  278  277  276  275  274  273  272  271  270  269  268  Older
DateSubjectAuthorDiscuss
16/9/2020
09:01
Do keep us updated on your permanent holiday destinations ny_boy, we are all so impressed by them and it is always so very relevant to the chat board subject...

I will be partying on the moon next week - and yes - that's not true either ;-)

seriously - what a tool you are.

growthinvestor2001
16/9/2020
08:51
Just a long term hold, great progress, very cheap dp imo

Stay patient here, I am relaxing on a Greek island this month a world away from Covid, a truly stunning island. Will check back here in October GLA long term holders

ny boy
16/9/2020
08:44
The fact is MULTIPLE offers have been received already and negotiations are at the advanced stage. This is what makes a near certainty we will have a partner in the due course.
frrinvest
16/9/2020
08:44
Spectacular ? !!!!
arab3
16/9/2020
08:43
Wow I didn't expect quite such a spectacular rise.....
nobbygnome
16/9/2020
08:37
Maybe me , secondary to my wonder at investors who own a share but just moan about the company etc .... genuinely does interest me !?

Anyway I’ve read it again and that really is a positive statement.

peachie 74
16/9/2020
08:36
Couldn’t add for the first 20 mins, very frustrating.
rafboy
16/9/2020
08:31
Well we have a nice rise now. Why on earth did the MMs mark it down first thing. Shouldn't complain as it was good for me though....😘
nobbygnome
16/9/2020
08:29
Not you Nobbygnome, it was earlier post by someone else
frrinvest
16/9/2020
08:27
Sometimes its the only way, but I get your point
bobaxe1
16/9/2020
08:26
>> frinvest

Are you referring to me? If so, I would hardly call my last post a lecture.....

nobbygnome
16/9/2020
08:23
I have been trying to top up this morning but can't buy just Negotiated Order which I don't do.
machinist
16/9/2020
08:13
RNS is pretty good. On a general note people have the right to express their opinion either way in a respectful manner. Nothing wrong with that so don't need any lecture from anyone thank you.
frrinvest
16/9/2020
08:11
>> lako

We are where we are. No-one is happy with the delay in signing the deal but you have to say that the report strongly suggests one will arrive soon. Assuming that is true the current valuation is ridiculous.

I bought a few more at 105p via spreadbet...

nobbygnome
16/9/2020
08:08
I would say that the decision to proceed with the paediatric study despite only having a cash runway into Q1 next year is a strange one.

On the whole the wording is very positive but no deal has been done and all financing options are theoretical.

lako42
16/9/2020
07:36
It looks like the price is going to open down, which I don't understand as I don't see any real negatives in the report. If it does, it certainly looks like a buying opportunity.

All just IMHO....

nobbygnome
16/9/2020
07:36
Have not had time to read as of yet. Any indication as to why the deal has gone back from the often communicated time frame of 'end of summer' to end of this year?
lako42
16/9/2020
07:33
Meh will pay for Christmas lol. Positive admittedly let's hope it's more lucrative than expected.
adman50
16/9/2020
07:31
And in the going concern statement they say debt or royalty financing should be available to them. So NO PLACING!!!!!!
nobbygnome
16/9/2020
07:23
Exactly Mark. That says it all. Not if , when.

Very good read IMO. Definite positive too regards China , massive market.

peachie 74
16/9/2020
07:21
Yes agree with Nobby that the key headline is:

We and our advisers have engaged with multiple companies, a number of which have signed confidentiality agreements, several have submitted non-binding offers and more detailed negotiations have been undertaken with a number of parties. We remain confident of securing a partner in 2020 and have recently ordered launch stocks of US packs of Accrufer® which should be available for sale by around the end of 2020.

markinvestor
16/9/2020
07:20
Have to agree - and they have 'recently ordered launch stocks of US packs of Accrufer(R) which should be available for sale by around the end of 2020'
photon
16/9/2020
07:13
Non binding offers have been received from US companies. There is tangible evidence of real progress and that a deal is close. The market cap here is ridiculous....
nobbygnome
Chat Pages: Latest  279  278  277  276  275  274  273  272  271  270  269  268  Older

Your Recent History

Delayed Upgrade Clock